USE OF THE FAT1 GENE AND ITS PRODUCTS, INCLUDING RNA, PROTEIN AND THE DERIVATIVES OF THE SAME, AS SUITABLE MOLECULE/S FOR TARGETING EITHER INFLAMMATION OR CANCER AND THE ASSOCIATED PHENOTYPE AND THE PROCESSES LINKING THE SAME AND ALSO AS A BIOMARKER FOR THE ABOVE PROCESSES.
The present invention relates to the use of the FAT I gene and its products, including RNA, protein and the derivatives of the same, as suitable targets for ameliorating either inflammation or cancer and the processes linking the same, or as a biomarker for the above processes.